There is another thing on Tuesday, April 6th.

After a month of running-in, Maoyuan Advertising and admonster underwent a preliminary merger.

Li Rui rushed to the company and witnessed this historic moment.

Everyone in Maoyuan has a dream. In October last year, they were still a traditional advertising company that could not be more traditional. In just half a year, they first transformed and merged, becoming the leading new media advertising company in the industry.

In the Haizhou advertising circle, when everyone mentioned Maoyuan advertisements, they would look puzzled and asked: What case did Maoyuan do?

After Li Rui had a series of lottery marketing on VB, and when he mentioned Maoyuan advertisements, everyone would like to say: Maoyuan, it was the one who won the lottery in VB!

In Haizhou advertising circle now, if there are still people who don’t know the name of Maoyuan advertising, this person must be out!

Maoyuan Advertising has transformed into a new multimedia commercial information advertising media company. After integrating admonster, it has the most powerful technical advantages in its industry.

In the new media advertising business, Maoyuan Advertising can provide a series of services ranging from commercial consultation, delivery forecasting, advertising production to performance monitoring, which is something that even some 4a advertising companies in the industry cannot do!

The company was full of joy, and even Ye Bingling, who was like an iceberg on weekdays, showed a rare smile.

After attending the ceremony, Li Rui chatted with Yan Zhaohonghui for a while before entering Ye Bingling's office.

After a long time no see, Ye Bingling has lost a lot.

"Chairman, why have you lost weight? Who abused you and won't give you food?" Li Rui said in surprise.

Ye Bingling glared at him: "Stop talking strange things, why do you have time to run over?"

"Today is the big day for Maoyuan Advertising. As a member of the company, I have to come and witness this historic moment!" Li Rui said.

Ye Bingling was angry and laughed: "Do you still know that you are a part of the company? I haven't seen you in a month?"

Li Rui coughed dryly: "I'm quite busy."

"Oh, what are you busy with? I haven't seen you attract big customers in such a busy time." Ye Bingling curled his lips.

Li Rui was about to speak, but his phone vibrated. It was a call from abroad.

He made a phone call to Ye Bingling, and Li Rui sat on the sofa in the office and answered the phone.

"Hello, Mr. Lee, I'm Michael Sofia."

"Hello Michael!" Li Rui smiled, "I'm very happy to receive your call. Call me so late. Is there anything important?"

It was almost noon, and it was already midnight in the country. Michael called at this time, and there must be something important.

Li Rui thought about it carefully and it seemed that Chen Qinglian had asked the second acquisition amount agreed by both parties to enter the pharmaceuticalset account a few days ago. Did it be spent so quickly?

"A big thing happened," Michael's tone was slightly excited, "I want to tell you good news!"

Li Rui's heart moved. Could it be that the results he was looking forward to finally arrived?

Sure enough, Michael said: "The psi-7851 developed by our team has very good therapeutic effects, but you also know that its synthesis steps cannot be effectively controlled, and will form a series of isomers, which brings strong side effects. For this reason, we chose a new technology and researched psi-7977 last month, which is an isomer of psi-7851. The synthesis process can be strictly controlled and will not cause side effects due to structural problems."

"You mean, we succeeded?" Li Rui asked.

Michael said: "We are conducting clinical trials and have been going on for three weeks now. From the perspective of the results, we can still maintain such good results in the next two months, then we can think that we have achieved initial success."

"Congratulations!" Li Rui said sincerely.

He knew that Michael had spent many years studying this new drug. Whether Michael saved more lives in medicine or made a lot of money, this kind of thing was ultimately a blessing for mankind and deserves praise and respect.

Michael said a little sourly: "I should congratulate you. If we had known that we would have been able to develop new results for another three months, I would not agree to your acquisition."

Li Rui laughed loudly, Michael is really too honest.

He smiled and said, "Michael, you should thank me for the funds I brought to you, which made you persist for an additional three months, otherwise you would fall before the finish line. Also, don't you think that I brought you good luck and that you suddenly found the secret to success after so many failures?"

"I'm joking with you," Michael said, "Maybe you're right, you brought me good luck!"

"What are your plans next?" Li Rui asked.

Michael said: "There are nine weeks left in phase II clinical testing, and we will closely observe the test. If the cure rate of hepatitis C type 2 and type 3 patients reaches 80% without significant side effects, we will continue to conduct the phase 3 trial."

"If all the trials go well, when will this drug be launched?" Li Rui asked.

Michael pondered: "After passing the third phase clinical test, you can apply to FDA (Magnesium Food and Drug Administration). This drug is the first treatment plan that can effectively cure hepatitis C without interferon. I think FDA should not set too much resistance. But even so, this process may take two to three years."

Li Rui said: "This is indeed exciting news, so I wish you good luck!"

After hanging up the phone, Li Rui couldn't help but wave his fist.

He invested so much money, and finally one investment could be rewarded.

In his previous life, Sofosbuvir was still in the third phase of clinical trials, and pharmaceutical company was acquired by Gilead, with a price of 11 billion magnesium!

If calculated based on Li Rui's 40% stake in pharmaceuticalsset, he can get a return of 4.4 billion magnesium, and his investment is a total of 200 million magnesium.ъìqυgΕtv.℃ǒΜ

And don’t forget that Li Rui also holds 50% of the profit rights of Sofosbuvir.

This means that if Gilead wants to fully acquire Sofobwe, it not only has to acquire pharmaset, but also has to buy the profit rights in Li Rui.

Perhaps Gilead could spend less money when acquiring pharmaset, but if you want to have Sofobwe in full, Gilead wouldn't be able to bleed much!

Li Rui thought, don’t ask for too much price.

Package pharmaset's equity and Sofosbuvir's income rights at a fixed price, 7 billion magnesium. If Gilead doesn't want it, just do it yourself!
Chapter completed!